AMETEK (NYSE:AME) Releases Q1 2026 Earnings Guidance

Posted by Dante Gardener on Feb 3rd, 2026

AMETEK (NYSE:AME – Get Free Report) issued an update on its first quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.850-1.900 for the period, compared to the consensus earnings per share estimate of 1.900. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.9 billion. AMETEK also updated its FY 2026 guidance to 7.870-8.070 EPS.

Analyst Ratings Changes

AME has been the topic of several recent analyst reports. Royal Bank Of Canada lifted their price target on shares of AMETEK from $212.00 to $229.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Truist Financial boosted their price target on shares of AMETEK from $219.00 to $229.00 and gave the company a “buy” rating in a research report on Wednesday, October 8th. Robert W. Baird raised their price objective on shares of AMETEK from $198.00 to $204.00 and gave the stock a “neutral” rating in a report on Monday, November 3rd. Deutsche Bank Aktiengesellschaft assumed coverage on AMETEK in a research report on Wednesday, January 21st. They set a “buy” rating and a $271.00 price objective on the stock. Finally, Melius Research set a $235.00 target price on AMETEK in a research report on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $229.82.

View Our Latest Stock Report on AME

AMETEK Trading Up 2.0%

NYSE AME opened at $228.48 on Tuesday. AMETEK has a 12 month low of $145.02 and a 12 month high of $229.03. The company has a current ratio of 1.16, a quick ratio of 0.72 and a debt-to-equity ratio of 0.14. The stock’s fifty day moving average price is $208.39 and its 200-day moving average price is $194.48. The stock has a market cap of $52.60 billion, a P/E ratio of 36.04, a P/E/G ratio of 3.05 and a beta of 1.03.

AMETEK Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Friday, December 5th were paid a dividend of $0.31 per share. The ex-dividend date was Friday, December 5th. This represents a $1.24 annualized dividend and a yield of 0.5%. AMETEK’s dividend payout ratio is currently 19.56%.

Insider Buying and Selling

In other AMETEK news, insider Thomas C. Marecic sold 14,310 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $202.11, for a total transaction of $2,892,194.10. Following the completion of the sale, the insider directly owned 42,589 shares in the company, valued at $8,607,662.79. The trade was a 25.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Thomas M. Montgomery sold 6,388 shares of the company’s stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $205.05, for a total transaction of $1,309,859.40. Following the sale, the vice president directly owned 22,116 shares of the company’s stock, valued at $4,534,885.80. The trade was a 22.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 137,088 shares of company stock worth $27,212,340. 0.57% of the stock is owned by insiders.

Trending Headlines about AMETEK

Here are the key news stories impacting AMETEK this week:

Positive Sentiment: Reported record fourth‑quarter and full‑year 2025 results, reinforcing underlying business strength. AMETEK Announces Record Fourth Quarter and Full Year Results
Positive Sentiment: Completed acquisition of LKC Technologies (adds ophthalmic diagnostic capabilities), expanding AMETEK’s medical/diagnostics exposure and product portfolio. AMETEK Acquires LKC Technologies DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK
Neutral Sentiment: Pre‑earnings coverage and previews highlight improving process markets and set context for investor expectations ahead of management commentary. Ametek Earnings on Deck as Process Markets Show Signs of Life Ametek Q4 2025 Earnings Preview
Negative Sentiment: Updated FY‑2026 EPS guidance of $7.87–$8.07 is slightly below the consensus of $8.00, signaling more modest full‑year growth than investors expected.
Negative Sentiment: Q1‑2026 EPS guidance of $1.85–$1.90 is at/just below the $1.90 consensus; revenue guidance centered around ~$1.9B also met modest expectations — collectively this conservative near‑term outlook is pressuring the stock.
Negative Sentiment: Giverny Capital trimmed its AMETEK position, citing valuation, which is a small negative signal about investor positioning. Giverny Capital Asset Management Trimmed Ametek (AME) on Valuation

Hedge Funds Weigh In On AMETEK

A number of hedge funds have recently made changes to their positions in AME. Sivia Capital Partners LLC bought a new stake in shares of AMETEK in the 2nd quarter worth about $295,000. Baird Financial Group Inc. grew its position in AMETEK by 16.1% in the second quarter. Baird Financial Group Inc. now owns 16,784 shares of the technology company’s stock worth $3,037,000 after acquiring an additional 2,323 shares in the last quarter. NewEdge Advisors LLC lifted its stake in shares of AMETEK by 65.0% in the 2nd quarter. NewEdge Advisors LLC now owns 3,946 shares of the technology company’s stock valued at $714,000 after purchasing an additional 1,555 shares during the last quarter. Sei Investments Co. boosted its holdings in shares of AMETEK by 38.2% in the 2nd quarter. Sei Investments Co. now owns 223,227 shares of the technology company’s stock worth $40,392,000 after purchasing an additional 61,672 shares during the period. Finally, Squarepoint Ops LLC increased its position in shares of AMETEK by 105.3% during the 2nd quarter. Squarepoint Ops LLC now owns 158,274 shares of the technology company’s stock valued at $28,641,000 after purchasing an additional 81,178 shares during the last quarter. Institutional investors own 87.43% of the company’s stock.

AMETEK Company Profile

(Get Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.